Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Κύριοι συγγραφείς: Min-Lan Tsai (Συγγραφέας), Hsiu-Chen Lin (Συγγραφέας), Chiung-Hui Yen (Συγγραφέας), Jung-Tzu Ku (Συγγραφέας), Shian-Ying Sung (Συγγραφέας), Hsi Chang (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2022-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...